We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Reports Citizen Petition Requirements Strain Resources
FDA Reports Citizen Petition Requirements Strain Resources
October 9, 2013
In a new report to Congress, the FDA reiterated the strain on agency resources required to respond to 505(q) citizen petitions requesting action on pending ANDAs, biosimilars or 505(b)(2) applications.